← Back to the library
InsomniaFebruary 10, 2024 · 10 min read

Dayvigo: The New Kid on the Insomnia Block

What is Dayvigo?

Dayvigo (lemborexant) for insomnia, with an unmarked tablet and a softly lit nighttime bedside scene
In this article

What is Dayvigo?

Dayvigo is the brand name for the drug lemborexant, which is an orexin receptor antagonist used to treat insomnia. Lemborexant belongs to a new class of medications called dual orexin receptor antagonists (DORAs).

Unlike other common sleep medications like zolpidem (Ambien), eszopiclone (Lunesta), or zaleplon (Sonata) which are GABA modulators, lemborexant works by blocking the activity of orexin, a neurotransmitter that promotes wakefulness. By inhibiting orexin receptors, Dayvigo helps decrease wake drive and facilitates sleep onset and maintenance.

History of Dayvigo

Dayvigo (lemborexant) is a new insomnia medication that was approved by the FDA in December 2019. It is manufactured by Eisai Inc., a Japanese pharmaceutical company that partnered with Purdue Pharma to develop the drug.

Clinical trials for Dayvigo began in 2014. Phase I trials looked at safety and dosage while Phase II and III focused on efficacy for sleep onset and sleep maintenance. In 2017, Eisai announced positive top-line results from a Phase III study showing Dayvigo helped insomnia patients fall asleep faster and stay asleep longer compared to placebo.

After successful late-stage clinical trials, Eisai submitted a new drug application for Dayvigo to the FDA in April 2019. In October 2019, the FDA approved Dayvigo for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. This made it the first FDA approved dual orexin receptor antagonist for insomnia.

Dayvigo entered the US market in April 2020, providing a new non-controlled substance option for adults struggling with sleep onset and sleep maintenance insomnia. Its approval added an important new class of medication for insomnia alongside more established options like benzodiazepines and Z-drugs.

How Dayvigo Works

Dayvigo (lemborexant) is an orexin receptor antagonist, which means it blocks the action of orexin in the brain. Orexin, also known as hypocretin, is a neurotransmitter that helps regulate wakefulness and sleep.

When orexin levels are high in the brain, it promotes wakefulness. Dayvigo works by selectively binding to orexin receptors, which blocks the stimulation of orexin and allows sleep to occur more easily.

Specifically, Dayvigo binds to OX1R and OX2R orexin receptors in the brain. This inhibits the downstream signaling which keeps you awake. By blocking these receptors, Dayvigo reduces the wake-promoting effects of orexin in the brain and induces sleep.

Studies show that Dayvigo helps improve sleep onset and sleep maintenance by dampening overactive orexin signaling. It reduces the time it takes to fall asleep and increases the amount of time spent in restorative NREM sleep.

Overall, Dayvigo induces sleep by suppressing the arousal system in the brain through antagonism of orexin receptors. This novel mechanism of action is different from other common sleep medications.

Evidence for Dayvigo

Dayvigo was approved by the FDA in 2019 for the treatment of insomnia based on results from clinical trials. The efficacy of Dayvigo was primarily studied in 3 randomized, double-blind, placebo-controlled studies involving over 2000 adults with insomnia.

In these studies, participants taking Dayvigo fell asleep significantly faster and stayed asleep longer compared to those taking a placebo. For example, in one study the median time to fall asleep was reduced from 27.8 minutes for placebo to 17.8 minutes for Dayvigo 10 mg.

The clinical trials also looked at sleep maintenance, which is the ability to stay asleep throughout the night without waking up. On average, Dayvigo significantly increased the time spent asleep versus placebo. In one 12-month study, Dayvigo helped participants sleep over 40 minutes longer compared to placebo.

Across all studies, Dayvigo demonstrated consistent benefits for sleep onset and sleep maintenance at doses between 5-30mg. The most common adverse effects were headache and somnolence. Overall the clinical trial data indicates Dayvigo is an effective treatment option for insomnia.

Dayvigo vs Other Sleep Medications

Dayvigo is a relatively new sleep medication that was approved by the FDA in 2020. It offers some potential advantages compared to other common prescription sleep aids such as Ambien (zolpidem), Lunesta (eszopiclone), and Belsomra (suvorexant).

One of the main differences is that Dayvigo is classified as an orexin receptor antagonist. It works by blocking orexin receptors in the brain which help regulate sleep-wake cycles. Other medications like Ambien work as GABA receptor agonists.

In studies, Dayvigo has been shown to help people fall asleep more quickly and stay asleep through the night. It may cause less next-morning drowsiness than some other options.

Dayvigo stays active in the body for a shorter period of time compared to Ambien or Lunesta. This could mean less lingering drowsiness, reduced risk of overnight falls, and lower potential for dependence or abuse.

However, more research is still needed to directly compare Dayvigo to other established sleep medications. The long-term efficacy and side effects of Dayvigo also require further study.

Talk to your doctor about whether Dayvigo or another sleep aid is more appropriate for your specific sleep issues and medical history. Cost and insurance coverage may also factor into the decision. Overall Dayvigo provides a newer alternative to consider for trouble sleeping, but other medications may still be better options for some patients.

Dayvigo Dosage

The recommended initial dose of Dayvigo is 5 mg taken orally once per night right before going to bed. For most patients, a 5 mg dose is adequate to improve sleep onset and sleep maintenance. If an initial 5 mg dose does not work well enough, the dose can be increased to a maximum of 10 mg once per night.

Dayvigo should be taken consistently at the same time every night before bed. It is designed to help patients fall asleep and stay asleep through the night when taken regularly as prescribed. Like with other sleep medications, taking Dayvigo only occasionally or sporadically is unlikely to result in optimal benefit.

For older adults aged 65 years and over, it is recommended to start at a lower dose of 5 mg taken once nightly. The dosage can be raised to 10 mg for elderly patients if the lower dose is well tolerated but not providing enough sleep improvement. However, extreme caution should be exercised when increasing Dayvigo doses in geriatric populations.

The maximum recommended dose of Dayvigo is 10 mg once nightly right before bedtime. Exceeding 10 mg per night is not advised, as it has not been studied and may increase side effects. If 10 mg is inadequate for treating insomnia symptoms, a different medication may need to be considered under medical guidance.

Dayvigo Side Effects

Like all medications, Dayvigo may cause side effects in some people. Most side effects are mild and temporary, but some can be serious.

Common Side Effects

The most common side effects of Dayvigo include headache, sleepiness, musculoskeletal pain, cold symptoms, and cough. These mild side effects tend to improve with continued use of the medication. Taking Dayvigo with food can help reduce some side effects like sleepiness.

Serious Side Effects

More concerning side effects are possible with Dayvigo, although they are much less common. These include sleep paralysis (inability to move while waking up), worsening depression and suicidal thoughts, complex sleep behaviors like sleep walking, sleep eating, or driving while asleep. Patients taking Dayvigo should be monitored closely for behavioral changes indicating these side effects.

Long-Term Effects

The long-term effects of taking Dayvigo are not yet fully known, since it is a newer drug approved by the FDA in 2019. No evidence currently suggests it causes addiction or dependence with long-term use. However, the long-term impacts of consistently altering sleep-wake cycles are not fully characterized. Patients taking Dayvigo for an extended time should have periodic check-ins with their doctor.

Pros of Dayvigo Compared to Other Sleep Medications

Dayvigo offers several key advantages compared to other prescription sleep medications such as Ambien, Lunesta, and Sonata:

- Dayvigo helps you fall asleep more quickly. Studies show patients taking Dayvigo fall asleep in under 30 minutes on average. This is faster than other common sleep meds.

- Dayvigo improves sleep quality. It increases time spent in deep sleep stages, resulting in more restorative rest.

- Dayvigo lasts through the night. It maintains its sleep-promoting effects for a full 8 hours, preventing middle of the night awakenings.

- Dayvigo causes less drowsiness the next day. Patients report less next-day sleepiness compared to other sleep medications, allowing you to wake up feeling refreshed.

- Dayvigo has a lower risk of dependence. It targets receptors involved in wakefulness rather than broadly sedating the brain like other sleep meds. This results in less potential for abuse and addiction.

- Dayvigo is non-habit forming. Clinical trials found no evidence of withdrawal effects or rebound insomnia after treatment discontinuation.

- Dayvigo has minimal drug interactions. It has a lower potential for negative interactions with other medications compared to similar sleep drugs.

Overall, Dayvigo provides faster sleep onset, better sleep quality, reduced next-day drowsiness, and a lower risk of dependence compared to popular alternatives like Ambien and Lunesta. These advantages make it a preferred option for many insomnia patients.

Disadvantages of Dayvigo

Compared to other commonly prescribed sleep medications like Ambien, Lunesta, and Sonata, Dayvigo has some notable drawbacks:

- It may cause unpleasant side effects like headache, cold-like symptoms, back pain, and cough. These types of side effects are less common with older sleep meds like Ambien.

- It can only be prescribed for adults ages 18 and over. Many other sleep meds are approved for patients as young as 12-16 years old.

- It requires proper timing - Dayvigo must be taken within 30 minutes before going to bed. This can be inconvenient compared to other meds that can be taken 1-2 hours before bedtime.

- There is less long-term safety data compared to older, established sleep medications that have been on the market for 20+ years. The long-term effects and safety profile of Dayvigo are less well known.

- It is expensive and often not covered by insurance, whereas generic Ambien and Lunesta are quite affordable. The high out-of-pocket cost makes Dayvigo less accessible.

- It is a controlled substance (C-IV) with potential for abuse and dependence, similar to other common sleep meds. It does not offer an advantage in this area.

- Dayvigo can potentially impair one's ability to drive and operate machinery the next morning, similar to other hypnotics. It does not cause less drowsiness upon waking compared to alternatives.

- Tolerance may develop after several weeks or months of continued use, requiring dosage adjustments or switching medications. This is also an issue with older sleep meds.

Overall, while Dayvigo is a novel medication, it does not appear to offer significant advantages over cheaper, older medications with longer track records of safety and effectiveness for insomnia. The disadvantages like side effects, high cost, and potential for dependence make it a second line option after trying older generics first. More research is needed to determine Dayvigo's place in insomnia treatment relative to established meds.

Conclusion

In summary, Dayvigo (lemborexant) is a promising new medication for treating insomnia. It works by blocking orexin receptors in the brain, helping patients fall asleep faster and stay asleep longer. Clinical trials have shown Dayvigo to be effective at improving sleep onset, sleep maintenance, and total sleep time compared to placebo.

The main advantages of Dayvigo are that it helps patients fall asleep quickly, allows them to stay asleep through the night, and leaves them feeling refreshed upon waking up. It does not seem to impair next-morning cognitive functioning or cause daytime drowsiness. The most common side effects are headache, somnolence, fatigue, and dizziness.

Overall, Dayvigo appears to be a beneficial treatment option for adults struggling with insomnia, especially those who have difficulty falling or staying asleep. While long-term safety data is still limited, the initial research is encouraging. For patients frustrated with current sleep medications, Dayvigo offers a fast-acting alternative without as many concerns over dependency and impairment. More research is still needed, but Dayvigo has the potential to significantly improve quality of life for insomnia patients.

Words worth knowing

Cognitive behavioral therapy (CBT)

A structured therapy that helps people notice patterns between thoughts, feelings, and actions, then practice more helpful responses.

Insomnia

A sleep disorder involving persistent difficulty falling asleep, staying asleep, or getting restorative sleep.

Dayvigo (Lamborexant): The New Kid on the Insomnia Block

Watch on YouTube

Educational content—not medical advice.Find support resources →